A hormone program has two agreements to understand: the medical plan and the payment plan. Joi’s public information puts both in view, with initial testing, continuing care and medication choices. The details deserve a careful read before a monthly headline becomes a recurring expense.

For this ledger entry, we examined Joi + Blokes’ hormone product and BHRT program pages in September 2026. We have not enrolled, ordered testing or interviewed patients. The aim is to identify what the pages establish and what a prospective patient still needs to ask.

In this entry

Identify the service you are buying

The BHRT overview presents testing, a clinician consultation and treatment delivery as parts of the process. The product listing shows several initial laboratory panels. A test purchase should be understood as a step toward assessment, not a promise of a prescription.

Before ordering, ask whether the program serves your location and whether it can evaluate the particular concern that brought you there. If you already have recent results, ask whether they are useful or whether another panel is required. Get that answer before paying for duplicate work.

Record the cash flow, not just the monthly rate

Joi publishes a $50 monthly equivalent for ongoing care, billed quarterly, with medication charged separately. Initial panels have their own listed prices and promotions. Record the actual amount due for testing, then the amount due when continuing care begins, rather than treating everything as one subscription.

For example, three months at that care rate equals $150 before medicine or initial testing. Enter your actual quote in the cost worksheet. Put a one-time laboratory charge in the laboratory field and a recurring care charge in the membership field. This keeps an introductory payment from disappearing inside a monthly average.

Resolve the cancellation wording

The public product information includes no-membership language while describing recurring care billing, and it refers to cancellation after the first three months. We would ask Joi to explain the agreement attached to a specific order, including the first cancellation date and whether stopping care also stops medication shipments.

That clarification is useful even if you expect to continue. A treatment change, move or unexpected expense can alter your plans. Ask what happens to prepaid care and unused medication, and save the terms provided at enrollment. We have not tested whether any particular refund request would be accepted.

Translate the medicine menu into a prescription

Joi lists estrogen, progesterone and testosterone in several forms, and its safety information identifies compounded options. A menu is not a personalized regimen. For every proposed item, request the ingredients, strength, route, frequency and pharmacy, using our prescription-reading guide.

Also ask whether the finished product is FDA-approved or compounded. A capsule or patch description alone is not enough to determine that status. If a compounded product is recommended, ask what need the formulation addresses and what approved alternatives were considered. Our approval and compounding notes explain the difference.

Understand why each test is ordered

A laboratory report can feel reassuring because it contains specific numbers. The useful follow-up question is how each relevant result changes the clinical decision. Ask the clinician to relate testing to your symptom history, current medications and other possible explanations for how you feel.

You should also know how repeat tests are scheduled, where samples are collected and whether additional tests carry charges. Do not adjust hormones to pursue a laboratory target on your own. A review needs to consider benefit and unwanted effects as well as any testing that is appropriate to your treatment.

Ask about the difficult parts of ongoing care

If systemic estrogen is proposed, the presence or absence of a uterus affects the discussion about progestogen. Ask the clinician to explain that component rather than assume any progesterone product provides equivalent protection. See our progesterone medicine guide for the questions to take into the appointment.

Testosterone also requires a separate rationale and location check; Joi publishes shipping restrictions for that medicine. Ask how a change in state, a side effect or an interrupted shipment would be handled. A convenient enrollment process is only one part of continuity, particularly when a prescription requires additional monitoring.

Compare a second care model

Joi’s online peers use different combinations of subscriptions, visits and pharmacy billing. Read Hone for another broad hormone program and MyMenopauseRx for a separate visit-and-pharmacy approach.

The most useful outcome is a written plan you can compare: why the treatment is proposed, what the first quarter costs and who will review it. The reviewed pages establish an offering to investigate. They do not establish that Joi delivers better clinical results than the alternatives or that every reader needs its laboratory-first approach.

CHECK THE ORIGINAL

The source record

Provider pages document their own offers. Medical and regulatory sources provide treatment context. This is not a record of personal patient testing. All sources checked September 20, 2026.

  1. Joi: hormone therapy products, lab options and billing
  2. Joi: ongoing BHRT program
  3. ACOG: compounded bioidentical menopausal hormone therapy, reaffirmed 2026
  4. FDA: understanding the risks of compounded drugs
  5. The Menopause Society: hormone therapy
This entry is educational. Decisions about a prescription belong with a licensed clinician who can assess your history. If you have a medical emergency, call 911.